$MDWD News

MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid®

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference

MediWound (MDWD) Q2 2026 Earnings Call Transcript

Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30

MediWound Ltd. Q2 2026 Earnings Call Summary

MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ...

MediWound Q2 Earnings Call Highlights

MediWound Ltd. (MDWD) Q2 2026 Earnings Call Transcript

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MediWound Q2 2026 Earnings Call: Complete Transcript

MediWound Q2 EPS $(0.77) Misses $(0.76) Estimate, Sales $3.092M Beat $2.588M Estimate

MediWound Affirms FY2026 Sales Guidance of $24.000M-$26.000M vs $24.125M Est

MediWound to Report Second Quarter 2026 Financial Results

Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely?

MediWound Ltd. Q1 2026 Earnings Call Summary

Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32

HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $36 Price Target

MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ...

MediWound (MDWD) Q1 2026 Earnings Transcript